Fig. 2From: A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulinComparison of individual changes in MAGE for each drug between the study baseline and endpoint. White circles and lines are mean and SD, respectivelyBack to article page